François Bachand

Crook J, Moideen N, Arbour G, Castro F, Araujo C, Batchelar D, Halperin R, Hilts M, Kim D, Petrik D, Rose J, Cheng JC, Bachand F

A Randomized Trial Comparing Quality of Life After Low-Dose Rate or High-Dose Rate Prostate Brachytherapy Boost With Pelvic External Beam Radiation Therapy

Int J Radiat Oncol Biol Phys, 120 (1), 2024.

Résumé | Liens:

Kudla M, Bachand F, Moore J, Batchelar D

Patient-specific cylinder templates for hybrid interstitial vaginal brachytherapy: Feasibility of automated 3-D design, 3D printing, and dosimetric outlook

Brachytherapy, 22 (4), 2023.

Résumé | Liens:

Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C,

Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study

J Clin Oncol, 41 (10), 2023.

Résumé | Liens:

Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC,

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

Lancet Oncol, 22 (4), 2021.

Résumé | Liens:

Parimi S, Bondy S, Aparicio M, Sunderland K, Cho J, Bachand F, Nguyen Chi K, Pickles T, Tyldesley S

Presenting stage and risk group in men dying of prostate cancer

Curr Oncol, 27 (6), 2020.

Résumé | Liens:

Parimi S, Bondy S, Tsang E, McKenzie MR, Bachand F, Aparicio M, Duncan G, Sunderland K, Olson RA, Pai HH, Alexander AS, LaPointe V, Chi KN, Tyldesley S

Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer

Can Urol Assoc J, 13 (10), 2019.

Résumé | Liens:

Halperin H, Hilts M, Crook J, Batchelar D, Tisseverasinghe S, Tetreault-LaFlamme A, Bachand F

A surrogate urethra for real-time planning of high-dose-rate prostate brachytherapy

Brachytherapy, 18 (5), 2019.

Résumé | Liens:

Cho CJ, Sunderland K, Pickles T, Bachand F, Chi KN, Tyldesley S

A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer

Pract Radiat Oncol, 9 (3), 2019.

Résumé | Liens:

Leung E, D'Souza D, Bachand F, Han K, Alfieri J, Huang F, Vigneault E, Barkati M, Wiebe EM, Foster W, Fortin I, Velker V, Bowes D, Barnes E, Patil N, Banerjee R, Barbera L, Ravi A

MRI-based interstitial brachytherapy for vaginal tumors: A multi-institutional study on practice patterns, contouring, and consensus definitions of target volumes

Brachytherapy, 18 (5), 2019.

Résumé | Liens:

Tissaverasinghe S, Crook J, Bachand F, Batchelar D, Hilts M, Araujo C, Anderson D, Bainbridge T, Farnquist B

Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial

Brachytherapy, 18 (3), 2019.

Résumé | Liens: